Skip to content
Explore the latest in web design, digital strategies, and t…

Zimbabwe Turns Down ‘One-Sided’ American Healthcare Assistance Deal Due to Information Apprehensions

Health funding illustration
The offered American funding would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) over five years due to Washington's request for confidential information.

This move was revealed following a official document from December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "unbalanced".

A government spokesman has since clarified that the US was demanding access to health data for scientific study and commercial gain but was unwilling to share the resulting advantages from future treatments.

"We must now begin the challenging and unfortunate process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had provided over $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for more talks to find a agreement acceptable to both sides so the nation's critical HIV programme can be sustained.

Broader Context

This rejection follows a similar situation in Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the safety of Kenyans' health data.

After returning to office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

The agency had administered aid for the US government, but Trump argued its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and responsibility.

Based on statements, 16 nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn in committed funds.

Specifics of the Declined Agreement

The funds for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this collaboration could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment through American-funded programmes," Tremont said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"The proposal required Zimbabwe to surrender its biological resources and data for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.

"Put simply, our country would supply the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our people if a future disease outbreak emerge."

National Interest and Global Health

He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting frameworks previously set up via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with future global health emergencies.

"This framework is intended to guarantee that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."

The government's concerns over the US deal "are not meant as anti-American sentiment," he added.

"We welcome continued dialogue with our American counterparts on how future collaboration might be designed in a way that honours the independence and interests of both nations."

Medical Community Response

Medical experts expressed it acknowledged the government's concerns, but recommended that talks must proceed considering much of the nation's HIV programmes relied on foreign aid.

"In cases where specific concerns exist, such as those involving information security or agreement terms, these can often be resolved through technical clarification and negotiated safeguards," it commented.

The situation underscores the complex tensions between receiving crucial foreign assistance and protecting a country's data in an ever more interconnected world.

Written by

Olivia Mathis

A digital strategist and UI/UX designer with over a decade of experience in creating immersive web experiences for global brands.

VistaFlow Blog

Type to search articles.